Regen BioPharma develops new approach for boosting CAR-T cell efficiency to treat solid tumors
Regen BioPharma, Inc. has filed with the United States Patent and Trademark Office a provisional…
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportRegen BioPharma, Inc. has filed with the United States Patent and Trademark Office a provisional…
Panbela Therapeutics, a U.S.-based clinical stage company, announced today (August 11) that it has enrolled…
Researchers at Queen’s University Belfast in Northern Ireland have revealed how the pathway of an…
A Polish biopharma company focused on treating cancer and autoimmune diseases announced today (August 10)…
A global collaboration was announced today (August 9) between Mersana Therapeutics Inc and GSK plc…
A medication used to treat non-small cell lung carcinomas (NSCLC) with specific mutations has demonstrated…
A trial to look at the use of a drug targeting refractory metastatic colorectal cancer…
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
This week’s podcast guests are Laura Fletcher, head of business development and strategic partnerships at…
Sanofi and Innovent Biologics are to collaborate on providing medicines to patients in China with…
A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory…
Researchers at Queen’s University Belfast in Northern Ireland have received funding from Breast Cancer Now…